Literature DB >> 24792267

The use of high-dose hydroxocobalamin for vasoplegic syndrome.

Joseph D Roderique1, Kofi VanDyck2, Brita Holman2, Daniel Tang2, Betty Chui2, Bruce D Spiess2.   

Abstract

We describe a case of hypotension on cardiopulmonary bypass for coronary artery bypass grafting, double valve repairs, and patent foramen ovale closure. The patient experienced vasoplegic syndrome while on cardiopulmonary bypass. He was treated with high-dose hydroxocobalamin (vitamin B12). His blood pressure responded rapidly, obviating any further vasopressor requirements.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24792267     DOI： 10.1016/j.athoracsur.2013.08.050

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  7 in total

1.  Rescue of Nimodipine-Induced Refractory Vasoplegia With Hydroxocobalamin in Subarachnoid Hemorrhage: A Case Report.

Authors:  Katherine M Clifford; Jai Madhok; Nick M Murray; Vibha Mohindra
Journal:  Crit Care Explor       Date:  2020-09-23

2.  High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm.

Authors:  Wisit Cheungpasitporn; John Hui; Kianoush B Kashani; Erica D Wittwer; Robert C Albright; John J Dillon
Journal:  Clin Kidney J       Date:  2017-03-15

3.  Refractory Vasoplegic Syndrome in an Adult Patient with Infective Endocarditis: A Case Report and Literature Review.

Authors:  Seyed Mohsen Mirhosseini; Ali Sanjari Moghaddam; Paritash Tahmaseb Pour; Ali Dabbagh
Journal:  J Tehran Heart Cent       Date:  2017-01

4.  Not all that is red is blood: a curious case of chromaturia.

Authors:  Abhilash Koratala; Gajapathiraju Chamarthi; Mark S Segal
Journal:  Clin Case Rep       Date:  2018-04-06

Review 5.  Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies.

Authors:  Theresa J Barnes; Maxwell A Hockstein; Craig S Jabaley
Journal:  SAGE Open Med       Date:  2020-06-25

6.  The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery.

Authors:  Yi Cai; Anwar Mack; Beth L Ladlie; Archer Kilbourne Martin
Journal:  Ann Card Anaesth       Date:  2017 Oct-Dec

7.  High-dose hydroxocobalamin in end-stage liver disease and liver transplantation.

Authors:  Sujit Vijay Sakpal; Hannah Reedstrom; Cody Ness; Tobin Klinkhammer; Hector Saucedo-Crespo; Christopher Auvenshine; Robert N Santella; Jeffery Steers
Journal:  Drugs Ther Perspect       Date:  2019-06-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.